583 related articles for article (PubMed ID: 16305311)
1. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
[TBL] [Abstract][Full Text] [Related]
2. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases.
Brenk R; Schipani A; James D; Krasowski A; Gilbert IH; Frearson J; Wyatt PG
ChemMedChem; 2008 Mar; 3(3):435-44. PubMed ID: 18064617
[TBL] [Abstract][Full Text] [Related]
3. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer T; Krovat EM
Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
[TBL] [Abstract][Full Text] [Related]
4. The synergy between combinatorial chemistry and high-throughput screening.
Diller DJ
Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
[TBL] [Abstract][Full Text] [Related]
5. Basic overview of chemoinformatics.
Engel T
J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
[TBL] [Abstract][Full Text] [Related]
6. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
Ghose AK; Viswanadhan VN; Wendoloski JJ
J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
[TBL] [Abstract][Full Text] [Related]
7. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
Piras P; Roussel C
J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
[TBL] [Abstract][Full Text] [Related]
8. Synthetic library design.
Huwe CM
Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
[TBL] [Abstract][Full Text] [Related]
9. Methods for combinatorial and parallel library design.
Schnur DM; Beno BR; Tebben AJ; Cavallaro C
Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
[TBL] [Abstract][Full Text] [Related]
10. Leadlikeness and structural diversity of synthetic screening libraries.
Verheij HJ
Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
[TBL] [Abstract][Full Text] [Related]
11. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
12. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
Martin E; Mukherjee P; Sullivan D; Jansen J
J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in library design: 'rational design' revisited.
Schnur DM
Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
[TBL] [Abstract][Full Text] [Related]
14. Learning from the data: mining of large high-throughput screening databases.
Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
[TBL] [Abstract][Full Text] [Related]
15. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
16. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
Edwards PJ
Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
[TBL] [Abstract][Full Text] [Related]
17. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
18. Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists.
Bradley EK; Miller JL; Saiah E; Grootenhuis PD
J Med Chem; 2003 Sep; 46(20):4360-4. PubMed ID: 13678414
[TBL] [Abstract][Full Text] [Related]
19. Reporting data from high-throughput screening of small-molecule libraries.
Inglese J; Shamu CE; Guy RK
Nat Chem Biol; 2007 Aug; 3(8):438-41. PubMed ID: 17637769
[TBL] [Abstract][Full Text] [Related]
20. Rational design approaches to chemical libraries for hit identification.
Balakin KV; Kozintsev AV; Kiselyov AS; Savchuk NP
Curr Drug Discov Technol; 2006 Mar; 3(1):49-65. PubMed ID: 16712463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
